(Stroke. 2001;32:2305.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Lenox Hill Heart and Vascular Institute of New York, New York.
Correspondence to Gary S. Roubin, MD, PhD, Lenox Hill Heart and Vascular Institute of New York, 130 E 77th St, New York, NY 10021. E-mail Groubin{at}Lenoxhill.net
Background and Purpose Ambulatory procedures increase patient comfort and enhance cost-effectiveness. We sought to determine the feasibility and safety of ambulatory carotid stenting.
Methods A selected group of patients was admitted and discharged the same day after the carotid stenting procedure. Immediate and short-term outcomes are reported.
Results A total of 98 ambulatory carotid stenting procedures (98 hemispheres in 92 patients) were performed. There were 66 men (72%), and the mean age was 70±9 years. Of the patients, 28% had neurological symptoms related to the treated artery within 3 months before the procedure. Sixteen percent of the patients had prior carotid endarterectomy, 4% had prior ipsilateral neck radiation, and 8% had complete occlusion of the contralateral internal carotid artery. Successful access site hemostasis was ensured in all patients with suture-mediated vascular closure devices in 96 (98%) and manual compression in 2. Clinical follow-up was available for 96% of the patients at a mean time of 6±4 months. There were no neurological events, deaths, repeated procedures, or major access site complications.
Conclusions Ambulatory carotid stenting is both safe and feasible. This approach will enhance the applicability of the procedure by increasing patient comfort and potentially reducing procedural costs.
This article has been cited by other articles:
![]() |
J. D. Barr, J. J. Connors III, D. Sacks, J. C. Wojak, G. J. Becker, J. F. Cardella, B. Chopko, J. E. Dion, A. J. Fox, R. T. Higashida, et al. Quality Improvement Guidelines for the Performance of Cervical Carotid Angioplasty and Stent Placement: Developed by a Collaborative Panel of the American Society of Interventional and Therapeutic Neuroradiology, the American Society of Neuroradiology, and the Society of Interventional Radiology AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 2020 - 2034. [Full Text] [PDF] |
||||
![]() |
A. Kastrup, K. Groschel, H. Krapf, B. R. Brehm, J. Dichgans, and J. B. Schulz Early Outcome of Carotid Angioplasty and Stenting With and Without Cerebral Protection Devices: A Systematic Review of the Literature Stroke, March 1, 2003; 34(3): 813 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Pelz Advances in Interventional Neuroradiology Stroke, February 1, 2003; 34(2): 357 - 358. [Full Text] [PDF] |
||||
![]() |
G. S. Roubin Angioplasty and Stenting Should Not Be Restricted to Clinical Trials Stroke, October 1, 2002; 33(10): 2520 - 2522. [Full Text] [PDF] |
||||
![]() |
F. Masuhr and M. Busch Ambulatory Carotid Stenting in Patients With Asymptomatic Carotid Artery Stenosis Stroke, April 1, 2002; 33(4): 1168 - 1169. [Full Text] [PDF] |
||||
![]() |
F. McKevitt, T. Cleveland, N. Al-Mubarak, G. S. Roubin, J. J. Vitek, G. New, and S. S. Iyer Is Ambulatory Carotid Stenting Safe? Too Early to Say Stroke, April 1, 2002; 33(4): 1169 - 1170. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |